Navigation Links
Efficacy Advantages and Long-Term Cost Savings Will Help Optimize Reimbursement in the EU5 for Type 2 Diabetes Agents
Date:8/26/2013

istration—positive cardiovascular outcomes data emerges as a primary preference for the GLP-1 analogues. Agents targeting these unmet needs should also help to address payer demands for downstream cost-savings, thus encouraging budget holders at all levels to think beyond the price tag as competition heightens among type 2 diabetes drug classes.    

However, the report also finds that as manufacturers strive for optimal pricing and reimbursement terms amid stringent HTA demands, they must be careful not to price themselves out of the market if they want to secure maximum uptake of their brands. Price must be carefully balanced with uptake potential for optimal return on investment.

"One quarter of surveyed GPs in Germany do not currently prescribe GLP-1 analogues to more than half of their eligible type 2 diabetes patients due to the constraints of their indicative prescribing budgets, while around two thirds of survey respondents in Spain report that their ability to prescribe DPP-IV inhibitors and GLP-1 analogues is at least somewhat impacted by recently increased patient copay," said Decision Resources Senior Director Janie Cox, Ph.D. "As the EU5 countries continue to feel the force of the economic crisis, industry is challenged with maximizing profitability at competitive rather than premium prices."

About Decision Resources

Decision Resources (www.decisionresources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources Group company.

About Decision Resources Group

Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sec
'/>"/>

SOURCE Decision Resources
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Renal Dialysis Equipment Market to 2017- Lower Costs and Similar Efficacy Rates as Hemodialysis to Increase Adoption Rates of Peritoneal Dialysis
2. MedQIA unique CAD algorithm for Quantitation of lung involvement in diffuse lung disease used as treatment efficacy end point in study to be reported at the ERS Annual Conference in Vienna, Austria: September 1-5, 2012
3. Lilly Stops Phase III Development of Pomaglumetad Methionil For the Treatment of Schizophrenia Based on Efficacy Results
4. Sosei Group Corporation: Data at ERS Shows Efficacy of Once-daily COPD Portfolio Versus Comparators, Further Establishes Dual-bronchodilator QVA149
5. Optimization of Comparative Efficacy Trials
6. JAMA Study Demonstrates Efficacy of Life Technologies Lung Cancer Test in Detecting Early Metastases, Supports Screening for Lung Cancer
7. Efficacy and Safety Data from Phase 2B Trials of Janssens Simeprevir in Hepatitis C Patients with Advanced Fibrosis of the Liver Presented at Annual Meeting of the American Association for the Study of Liver Diseases
8. OncoSec Medical Reports Positive Interim Efficacy Results from Phase IV Study of NeoPulse in Skin Cancer Patients
9. OncoSec Medical Reports Positive Preliminary Efficacy Results from Phase II Study of ImmunoPulse in Metastatic Melanoma Patients
10. Lilly Discontinues Phase 3 Rheumatoid Arthritis Program for Tabalumab Based on Efficacy Results
11. Data Demonstrating the Safety and Efficacy of Chimerixs Antiviral CMX001 Presented at BMT Tandem Meetings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/l8z67c/pharmaceutical ) has ... China (Basel, Switzerland - November 26-27, 2015)" conference to ... detailed overview of the key areas of pharmaceutical regulatory affairs ... , Macau and ... All important aspects of gaining and maintaining a successful Marketing ...
(Date:9/2/2015)... , Sept. 2, 2015  Seeger Weiss LLP ... bellwether trial will commence October 13, 2015. ... the 510K fast-track approval program, Zimmer NexGen knee implant ... only requires that companies provide evidence that the product ... in order to gain permissions. In ...
(Date:9/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/6x789c/new_eu ) has announced ... (London, UK - November 16-17, 2015)" conference to ... modules concerning Pharmacovigilance are a major departure in terms ... Europe . The intention of the course is ... how they overlap and fit together and what Companies ...
Breaking Medicine Technology:Pharmaceutical Regulatory Affairs in China Seminar: Basel, Switzerland - November 26-27, 2015 2Seeger Weiss LLP Reports That Zimmer NexGen Knee MDL Bellwether Trial Date Set For October 13, 2015 2
... NEW YORK, Jan. 13, 2011 Reportlinker.com announces ... in its catalogue: H. Lundbeck ... Introduction ... for Lundbeck in the prescription pharmaceutical sector. The ...
... 13, 2011 Reportlinker.com announces that a new ... Merck & Co., Inc.: PharmaVitae ... IntroductionThis analysis examines the historical and ... prescription pharmaceutical sector. The profile encompasses global company ...
Cached Medicine Technology:Reportlinker Adds H. Lundbeck A/S: PharmaVitae Profile 2Reportlinker Adds Merck & Co., Inc.: PharmaVitae Profile 2
(Date:9/3/2015)... ... , ... A scar is an unavoidable result of incision or injury to the skin. Unsightly ... heal itself. The appearance of a scar is dependent on many factors – the size ... ”Many scars fade to near invisibility on their own over a period of months,” says ...
(Date:9/3/2015)... ... September 03, 2015 , ... The new ... Report of Provo, Utah. The Clinicians Report is a leading information source to ... located throughout the U.S. Whiter Image's In-Office whitening kits were favorably validated for ...
(Date:9/3/2015)... ... September 03, 2015 , ... James Earl Jones will be hosting an upcoming ... James Earl Jones will introduce a segment that discusses why it is important for ... wellness can be fostered in any working environment. , Employers are out billions of ...
(Date:9/2/2015)... ... ... The Aspen Clinic (TAC), located in Basalt, Colorado, today announced ... wellness in the Roaring Fork Valley and beyond. , Amanda Wagner, Executive Director of ... fitness - we are much more than a gym. Our fitness and wellness ...
(Date:9/2/2015)... ... September 02, 2015 , ... The CRISPR-Cas9 system introduces ... of the Cas9 nuclease with either a chimeric single guide RNA (sgRNA) or two ... any given guide RNA (sgRNA or crRNA) to create a break in the target ...
Breaking Medicine News(10 mins):Health News:Do I Have To Live With That Scar? 2Health News:Do I Have To Live With That Scar? 3Health News:Do I Have To Live With That Scar? 4Health News:Whiter Image Products Get Positive Rating From The Clinicians Report 2Health News:James Earl Jones Hosts a New "Voices In America" Piece on Making the Workplace Healthier 2Health News:TAC Introduces New Retreats for Fall Fitness 2Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 2Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 3Health News:GE Healthcare Webinar Discusses Improvements to CRISPR-Cas9 Gene Editing 4
... Financial Options Guide Now Available at Sunrise Communities and ... (NYSE: SRZ ) now offers a new ... ideas for affording senior care in today,s challenging economy. ... Financial Options , is available at Sunrise communities nationwide ...
... to be a first-ever procedure, surgeons at Johns Hopkins ... small incision in the back of the donor,s vagina. ... the donor,s niece, and both patients are doing fine," ... division at Johns Hopkins University School of Medicine who ...
... Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ) ... call with simultaneous webcast on Tuesday, February 3, 2009 ... of Rigel,s senior management team will provide an update ... and Webcast Information To access the live call, please ...
... EPS Despite a Challenging Economic Environment BEDFORD, Mass., Feb. 2 ... HOLX ), a leading developer, manufacturer and supplier of premium ... the healthcare needs of women, today announced its results for ... quarter include: , ...
... common minimally invasive biopsy method used in the US, ... 14-gauge needle decreasing a physician,s chances of false-negative diagnoses, ... School of Medicine in Stanford, CA. , The ... using a 14-gauge or 11-gauge vacuum needle. Results showed ...
... February 02, 2009 The antiepileptic drug vigabatrin (VGB) has ... a special form of epilepsy in infants, called infantile spasm. ... it has been shown to cause a permanent narrowing of ... been exposed at school age or later. A new study ...
Cached Medicine News:Health News:Sunrise Senior Living Helps Families Explore Senior Care Financing Options with New Guide 2Health News:Hopkins transplant surgeons remove healthy kidney through donor's vagina 2Health News:Rigel to Host Conference Call on February 3, 2009 2Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 2Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 3Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 4Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 5Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 6Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 7Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 8Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 9Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 10Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 11Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 12Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 13Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 14Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 15Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 16Health News:Hologic Announces First Quarter Fiscal 2009 Operating Results 17Health News:Controversial medication may decrease spasms for infants with epilepsy 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: